Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma

Yang, WX; Xing, XB; Yeung, SCJ; Wang, SY; Chen, WF; Bao, Y; Wang, F; Feng, ST; Peng, F; Wang, XY; Chen, SL; He, MH; Zhang, N; Wang, HL; Zeng, B; Liu, ZG; Kidane, B; Seder, CW; Koyanagi, K; Shargall, Y; Luo, HH; Peng, S; Cheng, C

Cheng, C (通讯作者),Sun Yat Sen Univ, Dept Thorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022; 10 (1):

Abstract

Background Programmed cell death 1 (PD-1) blockade induces tumor regression in patients with advanced esophageal squamous cell carcinoma (ESCC); howev......

Full Text Link